Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 6Diarrhea 4Rectal Neoplasms 2Ovarian Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Short Bowel Syndrome 1Neoplasms 1Melanoma 1Lung Neoplasms 1Low Anterior Resection Syndrome 1Exanthema 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Colorectal Cancer Metastatic 1Colitis, Ulcerative 1Colitis 1Chemotherapy-related Diarrhea 1

Interventions

Infliximab 3Fecal Microbiota Transplantation 3vedolizumab 2Prednisone 2LDP-02 2Immunoglobulin G 2Disulfides 2CT-P13 2tocilizumab 1prednylidene 1fish oil triglycerides 1deltacortene 1Standard of Care 1Practice Guidelines as Topic 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Loperamide 1Injections 1Endoscopy 1Diagnosis 1Colonoscopy 1Cell- and Tissue-Based Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Colitis × Loperamide × Clear all
NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Recruiting
40 enrolled
BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡